00 days
00 hrs
00 mins
00 sec
        Adult Hematology Program                       Pediatric Hematology                       Nursing            
10 November 2021


11 November 2021


12 November 2021


13 November 2021




12 NOVEMBER 2021
ADULT HEMATOLOGY PROGRAM
07.40-08.40
 ORAL PRESENTATION SESSIONS 2
 Oktay Bilgir, İlhami Kiki, Alpay Yeşilaltay
SESSION 11 - New Thinking on Glanzmann Thrombasthenia: When Function Dominates and COAGULATION PROBLEMS
 CHAIRS: Drew Provan - Bülent Zülfikar
08.40-09.00
 New Therapies for Hemophilia Margareth C. Ozelo
09.00-09.20
 New Thinking on ITP
 Drew Provan 
09.20-09.40
 New Thinking on Glanzmann Thrombasthenia: When Function Dominates
 Hanan Hamed
09.40-10.00
 Coumadin and New Oral Anticoagulants: Which and When
 Özgür Mehtap
10.00-10.20
 GENERAL DISCUSSION Chair: Selami Koçak Toprak 
10.20-10.40
COFFEE BREAK

SESSION 12 - CHRONIC LYMPHOCYTIC LEUKEMIAS AND INDOLENT LYMPHOMAS

 CHAIRS: Robin Foà - Berksoy Şahin
10.40-11.00 Current Therapy of CLL 
 Antonio Cuneo
11.00-11.20 Indolent Lymphomas
 Carmino de Souza 
11.20-11.40 New Drugs for Low Grade Lymphoproliferative Disease 
 Argiris Simeonidis
11.40-12.00 Can We Cure CLL? 
  Robin Foà
12.00-12.20 GENERAL DISCUSSION Chair: Mehmet Turgut
12.20-13.20
LUNCH BREAK
13.20-14.00
 SATELLITE SYMPOSIUM-Response, The Rising Role of Venetoclax in the Era of Novel CLL Therapies
abbvi.png		 CHAIRS: Burhan Ferhanoğlu - SPEAKER: Mehmet Ali Özcan
SESSION 13 - SPECIAL TOPICS FOR LYMPHOMAS  
 CHAIRS: Anna Maria Sureda Balari - Burhan Ferhanoğlu
14.00-14.20
 Treatment of Relapsed/Refractory Diffuse large B Cell Lymphoma Burhan Ferhanoğlu
14.20-14.40
 Treatment of R/R Hodgkin Lymphoma
 Anna Maria Sureda Balari
14.40-15:00
 Response adapted maintenance therapy in FL:Lessons from the FOLL12 Trial
 Massimo Federico
15.00-15.20
 Treatment of R/R Follicular Lymphoma
 Stefano Luminari
15.20-15.40
 GENERAL DISCUSSION Chair: Olga Meltem Akay
15.40-16.00
COFFEE BREAK  

SESSION 14 - TRANSPLANTATION  

 CHAIRS: Arnon Nagler - Seçkin Çağırgan   
16.00-16.20
 Haplo vs MUD transpplant
 Arnon Nagler
16.20-16.40
 GVHD Treatment
 Elif Birtaş Ateşoğlu 
16.40-17.00
 Car-T Cell 
 Francesco Saglio
17.00-17.20
 Reduced Intensity Conditioning Treatment: Current View 
 Daniela Cilloni
17.20-17.40
 GENERAL DISCUSSION Chair: Hakan Göker
17.40-18.20
 SATELLITE SYMPOSIUM-Immunotherapies and Increased Opdivo Experiences in Turkey in the Treatment of R / R Hodgkin Lymphoma
bmsx50.png		 CHAIRS: Birol Güvenç - Mustafa Çetiner - SPEAKER: Mehmet Ali Özcan
SESSION 15 -   ACUTE LYMPHOBLASTIC LEUKEMIA  
 CHAIRS:Dieter Hoelzer  - Gülsüm Özet
18.20-18.40
 European Vision of ALL Treatment
 Dieter Hoelzer (Debate)
18.40-19.00
 American Vision of ALL Treatment
 Hagop Kantarjian (Debate)
19.00-19.20
 T-Cell ALL 
 Ali Bazarbachi
19.20-19.40
 Ph-Positive ALL 
 Robin Foà
19.40-20.00
 GENERAL DISCUSSION Chair:Sema Anak